Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: Clinical implications

Clinical Cancer Research

Volumn 9, Issue 1 I, 2003, Pages 195-200

  Ferrandina, Gabriella ^a   Pierelli, Luca ^a   Perillo, Alessandro ^a   Rutella, Sergio ^a   Ludovisi, Manuela ^a   Leone, Giuseppe ^a   Mancuso, Salvatore ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIRUBICIN; ETOPOSIDE; MELPHALAN; PACLITAXEL; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LEUKAPHERESIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NATURAL KILLER CELL; OVARY CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD56; FEMALE; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LYMPHOCYTES; OVARIAN NEOPLASMS; PROGNOSIS; RECEPTORS, IGG; RISK;

EID: 12244313414     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kessinger, A., and Armitage, J. O. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood. 77: 211-213, 1991.
2. Korbling, M., and Champlin, R. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts. Stem Cells, 14: 185-195, 1996.
3. Testa, U., Martucci, R., Rutella, S., Scambia, G., Sica, S., Benedetti Panici, P., Menichella, G., Leone, G., and Mancuso, S. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood, 84: 3532-3539, 1994.
4. Testa, U., Martucci, R., Scambia, G., Benedetti Panici, P., Mancuso, S., Camagna, G., Mastroberardino, G., Pierelli, L., Menichella, G., and Peschle, C. Autologous stem cell transplantation: exogenous granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor modulate the endogenous cytokine levels. Blood, 89: 2615-2617, 1997.
5. Pierelli, L., Perillo, A., Ferrandina, G., Salerno, G., Rutella, S., Fattorossi, A., Battaglia, A., Mughetti, A., Nuti, M., Cortesi, E., Leone, G., Mancuso, S., and Scambia, G. The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and M-CSF. Transfusion, 41: 1577-1585, 2001.
6. Bertz, H., Burger, J. A., Kunzmann, R., Mertelsmann, R., and Finke, J. Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (B MT): evidence for a graft-versus myeloma effect. Leukemia (Baltimore), 11: 281-283, 1997.
7. Ueno, N. T., Rondon, G., Mirza, N. Q., Geisler, D. H., Anderlini, P., Giralt, S. A., Andersson, B. S., Claxton, D. F., Gajevski, J. L., Khouri, I. F., Korbling, M., Mehra, R. C., Przepiorka, D., Rahman, Z., Samuels, B. I., van Besien, K., Hortobagyi, G. N., and Champlin, R. E. Allogeneic peripheral blood progenitor cell transplantation for poor risk patients with metastatic breast cancer. J. Clin. Oncol., 16: 986-993, 1998.
8. Marx, D., Meden, H., Ziemek, T., Lenthe, T., Kuhn, K., and Schauer, A. Expression of the p53 tumor suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer. Eur. J. Cancer, 34: 845-850, 1998.
9. Meden, H., Marx, D., Roegglen, T., Schauer, A., and Kuhn, W. Overexpression of the oncogene c-erbB-2 (Her2/neu) and response to chemotherapy in patients with ovarian cancer. Int. J. Gynecol. Pathol., 17: 61-65, 1998.
10. Porrata, L. F., Ingle, J. N., Litzow, M. R., Geyer, S. M., and Markovic, S. N. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Bone Marrow Transplant., 28: 865-871, 2001.
11. Salerno, M. G., Ferrandina, G., Greggi, S., Pierelli, L., Menichella, G., Leone, G., Scambia, G., and Mancuso, S. High dose chemotherapy as consolidation approach in advanced ovarian cancer: long term results. Bone Marrow Transplant., 27: 1017-1025, 2001.
12. Pierelli, L., Perillo, A., Greggi, S., Salerno, G., Benedetti Panici, P., Menichella, G., Fattorossi, A., Leone, G., Mancuso, S., and Scambia, G. Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral blood progenitor cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy. J. Clin. Oncol., 17: 1288-1295, 1999.
13. Pierelli, L., Menichella, G., Paoloni, A., Vittori, M., Foddai, M. L., Serafini, R., Rumi, C., Mitschulat, H., Rossi, P. L., Scambia, G., Teofili, L., Sica, S., Leone, G., and Bizzi, B. Evaluation of a novel automated protocol for the collection of peripheral blood stem cells mobilized with chemotherapy or chemotherapy plus G-CSF using the Fresenius AS 104 cell separator. J. Hematother., 2: 145-153, 1993.
14. Weisdorf, D. J., Verfaillie, C. M., Davies, S. M., Filipovich, A. H., Wagner, J. E., Jr., Miller, J. S., Burroughs, J., Ramsay, N. K., Kersey, J. H., and McGlave, P. B. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF. Blood, 85: 3452-3456, 1995.
15. Caballero, M. D., Vazquez, L., Barragan, J. M., Cruz, J. J., Gomez, A., Nieto, M. J., Corral, M., Fonseca, E., and San Migule, J. F. Randomized study of filgrastim versus molgrastim after peripheral stem cell transplant in breast cancer. Haematologica, 83: 514-518, 1998.
16. Cianciulli, A. M., Botti, C., Coletta, A. M., Buglioni, S., Marzano, R., Benevolo, M., Cione, A., and Mottolese, M. The contribution of fluorescence in situ hybridization to immunohistochemistry for evaluation of Her-2 in breast cancer. Cancer Genet. Cytogenet., 133: 66-71, 2002.
17. Ferrandina, G., Fagotti, A., Salerno, G., Natali, P. G., Mottolese, M., Maneschi, F., De Pasqua, A., Benedetti Panici, P., Mancuso, S., and Scambia, G. P53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer. Br. J. Cancer. 81: 733-740, 1999.
18. Ferrandina, G., Ranelletti, F. O., Lauriola, L., Fanfani, F., Legge, F., Mottolese, M., Nicotra, M. R., Natali, P. G., Zakut, V. H., and Scambia, G. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer. Gynecol. Oncol., 85: 305-310, 2002.
19. Cox, D. R. Analysis of binary data. London: Methven, 1970.
20. Kaplan, E., and Meyer, P. Nonparametric estimation from incomplete observations. J Am Statist Association, 53: 457-481, 1958.
21. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
22. Cox, D. R. Regression models and life tables. J. R. Stat. Soc., 34: 197-220, 1972.
23. Porrata, L. F., Gertz, M. A., Inwards, D. J., Litzow, M. R., Lacy, M. Q., Teffer, A., Gastineau, D. A., Dispenzieri, A., Ansell, S. M., Micaleff, I. N. M., Geyer, S. M., and Markovic, S. N. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin's lymphoma. Blood. 98: 579-585, 2001.
24. Horowitz, M. M., Gale, R. P., Sondel, P. M., et al. Graft versus leukemia reactions after bone marrow transplantation. Blood, 75: 555-562, 1990.
25. Bay, J. O., Choufi, B., Pomel, C., Dauplat, J., Durando, X., Tournilhac, O., Travade, P., Plagne, R., and Blaise, D. Potential allogeneic graft versus tumor effect in a patient with ovarian cancer. Bone Marrow Transplant., 25: 681-682, 2000.
26. Setti, M., Bignardi, D., Ballestrero, A., Ferrando, F., Masselli, C., Bianchi, S., Basso, M., Bosco, O., Balleari, E., Patrone, F., and Indiveri, F. The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor on the lymphocyte compartment in the course of high dose chemotherapy for breast cancer. Cancer Immunol. Immunother., 48: 287-296, 1999.
27. Rutella, S., Rumi, C., Laurenti, L., Pierelli, L., Sorá, F., Sica, S., and Leone, G. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants. Br. J. Haematol., 108: 105-115, 2000.
28. Douek, D. C., Vescio, R. A., Betts, M. R., Brenchley, J. M., Hill, B. J., Zhang, L., Berenson, J. R., Collins, R. H., and Koup, R. A. Assessment of thymic output in adults after hematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet, 355: 1875-1881, 2000.
29. Ometto, L., De Forni, D., Patiri, F., Trouplin, V., Mammano, F., Giacomet, V., Giaquinto, C., Douek, D., Koup, R., and De Rossi, A. Immune reconstitution in HIV-1 infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS, 16: 839-849, 2002.
30. Hildeman, D. A., Zhu, Y., Mitchell, T. C., Kappler, J., and Marrack, P. Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol., 14: 354-359, 2002.